Expertise in
10
conditions

Dr. David J. Goldberg

Dermatology
Skin Laser & Surgery Specialty Of NY & NJ
20 Prospect Avenue, Suite 702, 
Hackensack, NJ 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
10
conditions
Skin Laser & Surgery Specialty Of NY & NJ
20 Prospect Avenue, Suite 702, 
Hackensack, NJ 

Overview

David Goldberg is a Dermatologist practicing medicine in Hackensack, New Jersey.

Dr. Goldberg is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Comedones, Rosacea, Acne, and Sunburn.

Dr. Goldberg is board certified in American Board Of Dermatology. He is actively involved in clinical research, co-authoring 269 peer reviewed articles and participating in 11 clinical trials. Dr. Goldberg is currently accepting new patients.

Specialties

Dermatology

Licenses

Dermatology in NY

Board Certifications

American Board Of Dermatology

Fellowships

New York University Langone Medical Center

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Nippon Life
  • INSURANCE PLAN
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Skin Laser & Surgery Specialty of NY & NJ
20 Prospect Avenue, Suite 702, Hackensack, NJ 7601.

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 2 Efficacy and Safety Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Patients With Non-Gorlin High Frequency BCC
Enrollment Status: Terminated
Publish Date: July 21, 2026
Intervention Type: Drug
Study Drug: Patidegib
Study Phase: Phase 2
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
A Prospective Blinded Within-Subject Randomized Controlled Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
Enrollment Status: Completed
Publish Date: May 24, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
A Phase 2, Multi-Center, Randomized, Multiple Arm, Controlled Pilot Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Reducing Post- Keloidectomy Keloid Recurrence
Enrollment Status: Completed
Publish Date: March 19, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intralesional Injection of STP705 in Adult Patients With Cutaneous Squamous Cell Carcinoma in Situ (isSCC)
Enrollment Status: Completed
Publish Date: March 18, 2024
Intervention Type: Drug, Other
Study Drug: STP705
Study Phase: Phase 2
Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement
Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Device
Study Phase: Not Applicable
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Safety and Efficacy of Sofwave Treatment to Lift Lax Skin
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Device
Study Phase: Phase 3
Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks
Simultaneous Application of High-Intensity Focused Electromagnetic Procedure and Radiofrequency for Toning of Buttocks
Enrollment Status: Completed
Publish Date: February 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
Pilot Study to Evaluate VelaShape III & UltraShape Power Combined Treatment for Thigh Circumference Reduction
Enrollment Status: Completed
Publish Date: January 09, 2020
Intervention Type: Device
Study Phase: Not Applicable
View 9 Less Clinical Trials

269 Total Publications

The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.
The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.
Journal: Circulation
Published: March 25, 2026
Similar Doctors
Expertise in
17
conditions
Dr. Leon H. Kircik
Dermatology
Expertise in
17
conditions
Dr. Leon H. Kircik
Dermatology
Referral may be required

Clinical Pathology Associates

1425 Madison Ave, 
New York, NY 
 (8.5 miles away)
212-659-9530
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Leon Kircik is a Dermatologist practicing medicine in New York, New York. Dr. Kircik is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Acne, Plaque Psoriasis, Atopic Dermatitis, and Psoriasis. Dr. Kircik is currently accepting new patients.

Expertise in
9
conditions
Dr. Aimee S. Payne
Dermatology
Expertise in
9
conditions
Dr. Aimee S. Payne
Dermatology
Referral may be required

CUIMC/Herbert Irving Pavilion

161 Fort Washington Ave, 
New York, NY 
 (6.7 miles away)
914-768-8691
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Aimee Payne is a Dermatologist practicing medicine in New York, New York. Dr. Payne is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Pemphigus, Pemphigus Vulgaris, Pemphigus Foliaceus, and Bullous Pemphigoid. Dr. Payne is currently accepting new patients.

Expertise in
23
conditions
Expertise in
23
conditions
Referral may be required
Before you request

Office

1275 York Ave Ste 407, 
New York, NY 
 (9.6 miles away)
646-888-6018
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Patricia Myskowski is a Dermatologist practicing medicine in New York, New York. Dr. Myskowski is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses T-Cell Lymphoma, Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), and Lymphomatoid Papulosis. Dr. Myskowski is currently accepting new patients.

Frequently Asked Questions about Dr. David J. Goldberg

How do I make an appointment with Dr. David J. Goldberg?

You can book an appointment with Dr. David J. Goldberg by calling their office at 201-441-9890. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David J. Goldberg a top-rated expert for Comedones?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David J. Goldberg is classified as an Distinguished expert for Comedones, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David J. Goldberg specialize in?

While Dr. David J. Goldberg is a Dermatology, they have specific expertise in Comedones, Rosacea, and Acne. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. David J. Goldberg participate in research or clinical trials?

Yes. Dr. David J. Goldberg has published 269 articles and abstracts on conditions like Comedones. You can view a list of Dr. David J. Goldberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. David J. Goldberg accept my insurance?

Dr. David J. Goldberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 201-441-9890 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Goldberg's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 52 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile